Kanugo Abhishek, Bhattacharya Sankha
School of Pharmacy & Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India.
Department of Pharmaceutical Quality Assurance, SVKM Institute of Pharmacy, Dhule, Maharashtra 424001, India.
ACS Pharmacol Transl Sci. 2025 Apr 18;8(6):1438-1472. doi: 10.1021/acsptsci.4c00677. eCollection 2025 Jun 13.
This review provides a thorough summary of gastric cancer (GC), including its categorization, etiology, diagnosis, and the emerging use of immunotherapy in its treatment. It investigates the Correa Cascade, a development from normal mucosa to adenocarcinoma, and discusses the global incidence and mortality rates of GC. The article discusses the Lauren Classification, WHO classification, and tumor staging, emphasizing the necessity of early detection for optimal care. It investigates the different causes of GC, including , Epstein-Barr Virus, hereditary and environmental variables, and describes the diagnostic procedures utilized for early detection. Finally, this review aims to provide an in-depth breakdown and overview of the most important topics in GC and immunotherapy, including disease development, classification, risk factors, early detection methods, treatment options, and the growing significance of immunotherapy, as well as the importance of biomarkers, ongoing clinical trials, and immunotherapy's potential to treat GC.
本综述全面总结了胃癌(GC),包括其分类、病因、诊断以及免疫疗法在其治疗中的新兴应用。它研究了从正常黏膜发展为腺癌的科雷亚级联反应,并讨论了全球胃癌的发病率和死亡率。文章讨论了劳伦分类、世界卫生组织分类和肿瘤分期,强调了早期检测对于最佳治疗的必要性。它研究了胃癌的不同病因,包括爱泼斯坦-巴尔病毒、遗传和环境变量,并描述了用于早期检测的诊断程序。最后,本综述旨在深入剖析和概述胃癌及免疫疗法中最重要的主题,包括疾病发展、分类、危险因素、早期检测方法、治疗选择以及免疫疗法日益增长的重要性,还有生物标志物的重要性、正在进行的临床试验以及免疫疗法治疗胃癌的潜力。